Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells

Regulatory Peptides

Volumn 172, Issue 1-3, 2011, Pages 16-22

  Albertin, Giovanna ^a   Guidolin, Diego ^a   Sorato, Elisa ^a   Oselladore, Barbara ^a   Tortorella, Cinzia ^a   Ribatti, Domenico ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Angiogenesis; Angiogenic factors; Human endothelial cells; Urotensin II

Indexed keywords

ADRENOMEDULLIN; ENDOTHELIN 1; UROTENSIN II; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANGIOGENESIS INDUCING AGENTS; CELLS, CULTURED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOASSAY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; UROTENSINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053571192     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.08.001     Document Type: Article

References (42)

1. Pearson D., Shively J.E., Clark B.R., Geschwind I.I., Barkley M., Nishioka R.S., et al. Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci USA 1980, 77:5021-5024.
2. Davenport A.P., Maguire J.J. Urotensin II: fish neuropeptide catches orphan receptor. Trends Pharmacol Sci 2000, 21:80-92.
3. Maguire J.J., Kuc R.E., Kleinz M.J. Davenport AP immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function. Peptides 2008, 29:735-742.
4. Matsushita M., Shichiri M., Imai T., Iwashina M., Tanaka H., Takasu N., et al. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. J Hypertens 2001, 19:2185-2190.
5. Ames R.S., Sarau H.M., Cambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., et al. Human urotensin II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999, 401:282-286.
6. Douglas S.A., Ohlstein E.H. Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease. Trends Cardiovasc Med 2000, 10:229-237.
7. Thanassoulis G., Huyhn T., Giaid A. Urotensin II and cardiovascular diseases. Peptides 2004, 25:1789-1794.
8. Papadopoulos P., Bousette N., Giaid A. Urotensin-II and cardiovascular remodeling. Peptides 2008, 29:764-769.
9. Ribatti D., Conconi M.T., Nussdorfer G.G. Nonclassic endogenous regulators of angiogenesis. Pharmacol Rev 2007, 59:185-205.
10. Guidolin D., Albertin G., Ribatti D. Urotensin-II as an angiogenic factor. Peptides 2010, 31:1219-1224.
11. Spinazzi R., Albertin G., Nico B., Guidolin D., Di Liddo R., Rossi G.P., et al. Urotensin-II and its receptor (UT) are expressed in rat brain endothelial cells, and urotensin-II via UT stimulates angiogenesis in vivo and in vitro. Int J Mol Med 2006, 18:1107-1112.
12. Albertin G., Guidolin D., Sorato E., Spinazzi R., Mascarin A., Oselladore B., et al. Pro-angiogenic activity of urotensin-II on different human vascular endothelial cell populations. Regul Pept 2009, 157:64-71.
13. Guidolin D., Albertin G., Oselladore B., Sorato E., Rebuffat P., Mascarin A., et al. The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways. Regul Pept 2010, 162:26-32.
14. Shi X.-D., Li Z.-L., Wu H.-C., Wang T.-H., Fu Q., Yan Q.-N., et al. Mechanism of urotensin II-stimulated adrenomedullin secretion in human vascular endothelial cells. Di Yi Jun Yi Da Xue Xue Bao 2005, 25:791-793.
15. Tsai C.-S., Loh S.-H., Liu J.-C., Lin J.-W., Chen Y.-L., Chen C.-H., et al. Urotensin-II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Atherosclerosis 2009, 206:86-94.
16. Xu H., Czerwinski P., Hortmann M., Sohn H.-Y., Förstermann U., Li H. Protein kinase C α promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovasc Res 2008, 78:349-355.
17. Clozel M., Binkert C., Birker-Robaczewska M., Boukhadra C., Ding S.S., Fischli W., et al. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin system. J Pharmacol Exp Ther 2004, 311:204-212.
18. Conconi M.T., Lora S., Baiguera S., Boscolo E., Folin M., Scienza R., et al. In vitro culture of rat neuromicrovascular endothelial cells on polymeric scaffolds. J Biomed Mater Res 2004, 71:669-674.
19. Albertin G., Carraro G., Nussdorfer G.G. Human adrenomedullin gene silencing by short interfering RNAs: a preliminary study. Int J Mol Med 2005, 15:579-583.
20. Albertin G., Rucinski M., Carraro G., Forneris M., Andreis P.G., Malendowicz L.K., et al. Adrenomedullin and vascular endothelium growth factor genes are overexpressed in the regenerating rat adrenal cortex, and AM and VEGF reciprocally enhance their mRNA expression in cultured rat adrenocortical cells. Int J Mol Med 2005, 16:431-435.
21. Guidolin D., Albertin G., Spinazzi R., Sorato E., Mascarin A., Cavallo D., et al. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2. Peptides 2008, 29:2013-2023.
22. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res 2001, 29:e45.
23. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acid Res 2002, 30:e36.
24. Fong T., Shawver L.K., Sun L., Tang C., App H., Powell T.J., et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization and growth of multiple tumor types. Cancer Res 1999, 59:99-106.
25. Guidolin D., Vacca A., Nussdorfer G.G., Ribatti D. A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. Microvasc Res 2004, 67:117-124.
26. Merks R.M.H., Brodsky S.V., Goligorsky M.S., Newman S.A., Glazier J.A. Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling. Dev Biol 2006, 289:44-54.
27. Guidolin D., Albertin G., Sorato E., Oselladore B., Mascarin A., Ribatti D. Mathematical modeling of the capillary-like pattern generated by adrenomedullin-treated human vascular endothelial cells in vitro. Dev Dyn 2009, 238:1951-1963.
28. Guidolin D. The multifaceted world of angiogenesis control. Expert Opin Ther Targets 2010, 14:1135-1138.
29. Ribatti D., Nico B., Spinazzi R., Vacca A., Nussdorfer G.G. The role of adrenomedullin in angiogenesis. Peptides 2005, 26:1670-1675.
30. Deville J.L., Salas S., Figarella-Branger D., Ouafik L., Daniel L. Adrenomedullin as a therapeutic target in angiogenesis. Expert Opin Ther Targets 2010, 14:1059-1072.
31. Ribatti D., Guidolin D., Conconi M.T., Nico B., Baiguera S., Parnigotto P.P., et al. Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene 2003, 22:6458-6461.
32. Kim W., Moon S.O., Sung M.J., Kim S.H., Lee S.O., So J.N., et al. Angiogenic role of adrenomedullin through activation of Akt mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 2003, 13:1937-1939.
33. Fernandez-Sauze S., Delfino C., Mabrouk K., Dussert C., Chinot O., Martin P.M., et al. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CLR/RAMP2 and CLR/RAMP3 receptors. Int J Cancer 2004, 108:797-804.
34. Albertin G., Sorato E., Oselladore B., Mascarin A., Tortorella C., Guidolin D. Involvement of vascular endothelial growth factor signaling in CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on human vascular endothelial cells. Int J Mol Med 2010, 26:289-294.
35. Golikorsky M.S., Budzikowski A.S., Tsukahara H., Noiri E. Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis. Clin Exp Pharmacol Physiol 1999, 26:269-271.
36. Noiri E., Hu Y., Bahou W.F., Keese C.R., Giaever I., Golikorsky M.S. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J Biol Chem 1997, 272:1747-1752.
37. Salani D., Taraboletti G., Rosanò L., Di Castro V., Borsotti P., Giavazzi R., et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 2000, 157:1703-1711.
38. Shichiri M., Kato H., Marumo F., Hirata Y. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension 1997, 30:1198-1203.
39. Shichiri M., Yokokura M., Marumo F., Hirata Y. Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 2000, 20:989-997.
40. Suguro T., Watanabe T., Ban Y., Kodate S., Misaki A., Hirano T., et al. Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am J Hypertens 2007, 20:211-217.
41. Heringlake M., Kox T., Uzun O., Will B., Bahlman I., Klaus S., et al. The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease. Regul Pept 2004, 121:129-136.
42. Watanabe T., Kanome T., Miyazaki A., Katagiri T. Human urotensin II as a link between hypertension and coronary artery disease. Hypertens Res 2006, 29:375-387.